Severe COVID-19 Can Reactivate Dormant Viruses and Trigger Autoimmune Issues

Clinical research demonstrates that severe acute respiratory coronavirus infections can awaken dormant viruses harbored within the human body. Medical investigators link this viral reactivation phenomenon to persistent post-acute sequelae and the development of secondary autoimmune conditions.

Latent pathogens such as Epstein-Barr virus often remain suppressed by a functioning immune system under normal physiological circumstances. Severe viral infections induce profound immune system dysregulation, allowing these dormant agents to replicate and provoke sustained inflammatory responses.

Specialists are evaluating targeted antiviral and immunomodulatory therapies to address persistent symptoms experienced by long COVID patients. Understanding these viral triggers helps physicians develop more effective treatment protocols for chronic post-viral illness.